The ruling by the U.S. Supreme Court to overturn Roe v. Wade and leave the decision of abortion to the states has been a big topic over the last few days. An analyst singles out a pharmaceutical company that could benefit from increased purchases of over-the-counter contraceptives.
The Perrigo Analyst: Raymond James analyst Elliot Wilbur has an Outperform rating on Perrigo Company (NYSE:PRGO).
